Related Experiment Videos
Data from the Dublin outcome study
Eamon Dolan1, Jan A Staessen, Eoin O'Brien
1Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Cambridge, UK.
Insights
Ambulatory blood pressure monitoring (ABPM) better predicts cardiovascular events than clinic measurements. A novel index, ambulatory arterial stiffness index (AASI), derived from ABPM, also proves valuable for prognosis.
Area of Science:
- Cardiovascular Medicine
- Hypertension Research
- Clinical Epidemiology
Background:
- Ambulatory blood pressure monitoring (ABPM) offers superior cardiovascular event prediction compared to clinic blood pressure measurement (CBPM).
- Cardiovascular risk management relies on accurate prognostic indicators.
- The Dublin Outcome Study aimed to assess predictive values of ABPM indices.
Purpose of the Study:
- To evaluate established and novel ABPM indices for cardiovascular risk prediction.
- To determine the prognostic value of ABPM in a large patient cohort.
- To compare ABPM-derived indices against traditional cardiovascular risk factors.
Main Methods:
- 11,291 untreated patients underwent ABPM at baseline.
- Ambulatory arterial stiffness index (AASI) calculated as 1 minus the regression slope of diastolic vs. systolic BP.
- Cox proportional-hazards models used for survival analysis over a median 5.3-year follow-up.
Main Results:
- 566 cardiovascular deaths occurred during follow-up.
- An abnormal AASI was associated with a 2.05-fold increased risk of cardiovascular death (unadjusted).
- Adjusted hazard ratio for abnormal AASI was 1.59, indicating independent prognostic value.
Conclusions:
- ABPM is a superior method for predicting cardiovascular mortality over CBPM.
- AASI, a simple index derived from ABPM, is a novel and significant prognostic tool.
- AASI enhances cardiovascular risk stratification and patient management.
Background:
Ambulatory blood pressure monitoring (ABPM) has proven to be a superior predictor of cardiovascular events when compared with clinic or office blood pressure measurement (CBPM). The purpose of the Dublin Outcome Study was to evaluate the predictive value of various established and new ABPM indices in a large sample of patients referred for management of cardiovascular risk.
Methods And Results:
At baseline 11,291 patients (5326 men, mean age 54.6 years), who were not on antihypertensive medication, underwent ABPM. Using all blood pressure readings from each individual, diastolic blood pressure was plotted against systolic blood pressure, and the regression slope was calculated. Ambulatory arterial stiffness index (AASI) was defined as one minus this regression slope. After a median follow-up of 5.3 years there were 566 cardiovascular deaths. In a Cox proportional-hazards model the unadjusted and adjusted (for other cardiovascular risk factors, mean arterial pressure and pulse pressure) hazard ratios for an abnormal AASI were 2.05 (95% confidence intervals; 1.60-2.63, P<0.0001) and 1.59 (1.23-2.04, P=0.001) respectively.
Conclusions:
ABPM is superior to clinic or office blood pressure measurement in predicting cardiovascular mortality AASI, which may be derived simply from ABPM, is a novel index in determining prognosis.
Related Concept Videos
Longitudinal Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One example of...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Bioavailability Study Design: Single Versus Multiple Dose Studies